![Eui-Jong Kwak](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Eui-Jong Kwak
Director/Board Member at
CELLID, CO., LTD.
Net worth: 8 147 $ as of 2026-06-29
Profile
Eui-Jong Kwak currently works at Cellid Co., Ltd., as Non-Executive Director from 2023.
Mr. Kwak also formerly worked at SAMIL PHARMACEUTICAL Co., Ltd., as President-Executive Board, Head-R&D.
Mr. Kwak received his undergraduate degree, graduate degree, and doctorate degree from Seoul National University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
CELLID CO., LTD. 0.03% | 2025-06-29 | 8,977 ( 0.03% ) | 8 147 $ | 2026-06-29 |
Eui-Jong Kwak active positions
| Companies | Position | Start |
|---|---|---|
| CELLID, CO., LTD. | Director/Board Member | 2023-03-28 |
Former positions of Eui-Jong Kwak
| Companies | Position | End |
|---|---|---|
| SAMIL PHARMACEUTICAL CO.,LTD | Chief Tech/Sci/R&D Officer | - |
Training of Eui-Jong Kwak
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
SAMIL PHARMACEUTICAL Co., Ltd.
 SAMIL PHARMACEUTICAL Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in the development and manufacture of pharmaceutical products | Health Technology |
Seoul National University
 Seoul National University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cellid Co., Ltd.
 Cellid Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes immunotherapeutic vaccines | Health Technology |
- Stock Market
- Insiders
- Eui-Jong Kwak
